Familial hypercholesterolemia - past and present. My experiences and findings in our group of patients with familial hypercholesterolemia

Abstract

Currently, the familial hypercholesterolemia (FH) rises the interest. The reason is that this genetic disorder is targeted by newly emerged and highly effective hypolipidemic agents, PCSK-9 inhibitors, lomitapid and mipomersen.

Present paper discusses 2 patient study groups, before 50years and nowadays.

Keywords

• CAD
• familial hypercholesterolemia
• HDL-cholesterol
• LDL-cholestrerol
• triglycerides
• xanthoma